Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Current treatments for alopecia show no significant long-term benefits.

Alopecia areata is caused by the immune system attacking hair follicles.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

Netherton's syndrome is linked to high IgE levels and unique skin and hair symptoms, and may improve with ammonium lactate lotion and allergy management.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

No single treatment is consistently effective for alopecia areata, and more research is needed.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The study found that steroids and tetracycline helped treat active Lichen planopilaris, and hair transplants were good for later stages.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Topical cyclosporine lotion led to hair regrowth in a man with alopecia universalis.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Topical corticosteroids are the best initial treatment for children's alopecia areata.